A phase 2 trial of intravenous and intraperitoneal paclitaxel combined with S-1 for treatment of gastric cancer with macroscopic peritoneal metastasis

Intraperitoneal docetaxel combined with S-1 for advanced gastric cancer with peritoneal dissemination

(2011) Yoshiyuki Fujiwara et al.   JOURNAL OF SURGICAL ONCOLOGY

Spatial distribution of intraperitoneally administrated paclitaxel nanoparticles solubilized with poly (2-methacryloxyethyl phosphorylcholine-co n-butyl methacrylate) in peritoneal metastatic nodules

(2010) Takao Kamei et al.   CANCER SCIENCE

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

(2010) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis

(2009) H. Ishigami et al.   ANNALS OF ONCOLOGY

Intraperitoneal administration of paclitaxel solubilized with poly(2-methacryloxyethyl phosphorylcholine-con-butyl methacrylate) for peritoneal dissemination of gastric cancer

(2009) Daisuke Soma et al.   CANCER SCIENCE

Safety and efficacy of bidirectional chemotherapy for treatment of patients with peritoneal dissemination from gastric cancer: Selection for cytoreductive surgery

(2009) Yutaka Yonemura et al.   JOURNAL OF SURGICAL ONCOLOGY

Phase I Pharmacokinetic Study of Weekly Intravenous and Intraperitoneal Paclitaxel Combined with S-1 for Advanced Gastric Cancer

(2009) Hironori Ishigami et al.   ONCOLOGY

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial

(2008) Wasaburo Koizumi et al.   LANCET ONCOLOGY